UTI Healthcare Fund Regular Plan-IDCW Payout

Mutual Fund Details – Invest Smart, Grow Wealth

Discover a variety of mutual funds tailored to your goals, from equity and debt to hybrid options. Track performance, compare funds, and get expert insights to make informed investment decisions. Grow your wealth with Motilal Oswal’s trusted mutual fund solutions.

Equity, Sectoral-Pharma, Principal at very high risk

1 Year Return 1.07% at 05 Feb 2026 10:35 AM

mf-nav

Fund Details

NAV 213.5663

Sub-Type Sectoral-Pharma

Rating 4

Min. SIP Amount ₹500.0

Fund Age(Year) 26.61

Fund Size(in Crores) 1101.62

Fund Performance

1 Month -3.69%

3 Month -5.63%

6 Month -5.4%

1 Year 1.07%

3 Year 24.37%

5 Year 14.42%

Know This Fund

As on 05 Feb 2026

Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.

Equity (99.4%) Market Cap Mid Cap 38.09 Large Cap 16.4 Small Cap 44.91 Top Sectors Healthcare 99.4 Top Holding Divi's Laboratories 2.9 Dr. Reddy's Laboratories 3.46 Laxmi Dental 0.37 Ipca Laboratories 2.02 Torrent Pharmaceuticals 0.7 Acutaas Chemicals 0.98 Dr. Lal Pathlabs 1.08 Emcure Pharmaceuticals 0.93 Krishna Institute 1.95 Ajanta Pharma 7.16 Alkem Laboratories 3.4 Anthem Biosciences 1.79 Biocon 0.72 Orchid Pharma 0.69 Cipla 3.43 Glenmark Pharmaceuticals 4.06 Alembic Pharmaceuticals 0.76 Aurobindo Pharma 2.68 Metropolis Healthcare 1.69 Jupiter Life Line Hospitals 2.87 Syngene International 1.06 Procter & Gamble Health 3.46 Sanofi Consumer Healthcare India 0.99 Jubilant Pharmova 0.87 Apollo Hospitals Enterprise 3.39 Windlas Biotech 1.13 Sai Life Sciences 1.89 Pfizer 1.75 Sudeep Pharma 1.37 Fortis Healthcare 2.81 Global Health 2.05 Sequent Scientific 2.07 Max Healthcare Institute 2.74 Lupin 5.65 Sun Pharmaceutical Industries 9.37 Rainbow Children's 0.94 Caplin Point Laboratories 2.42 Eris Lifesciences 2.05 Gland Pharma 3.6 Vijaya Diagnostic Centre 1.16 Cohance Lifesciences 1.85 Marksans Pharma 1.44 Aster DM Healthcare 1.71

Debt & Others (0.6%) Sector Allocation CBLO 0.01 Net Current Assets 0.59 Debt Credit Ratings Debt Category Others 0.6

Comparison with same funds

Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M -2.71% Ret 1Y 1.89% Ret 3Y 21.9% Ret 5Y 12.99%

Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M -2.71% Ret 1Y 1.89% Ret 3Y 21.9% Ret 5Y 12.99%

Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M -2.71% Ret 1Y 1.89% Ret 3Y 21.9% Ret 5Y 12.99%

Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -3.8% Ret 1Y -1.64% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -3.8% Ret 1Y -1.64% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -3.8% Ret 1Y -1.64% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M -4.34% Ret 1Y -1.42% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M -5.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M -5.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M -5.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M -3.11% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%

Charges & Taxes Expense Ratio

Returns are taxed as per your Income Tax Slab.

Expense Ratio (Inclusive of GST): 2.27%

Exit Load 0%

Stamp Duty 0.005%

Fund Management

The various expenses, charges and taxes associated with your Mutual Fund

Kamal Gada

Education Mr. Gada is B.com, CA, CS, & CFA

Experience Prior to joining UTI Mutual Fund he has worked with BPCL as Senior Accounts Officer.

Riskometer

Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.

Principal at very high risk

AMC and Fund details

Rank (total sets) 5

Date of Incorporation 1999-06-28

Total AUM 2025-12-31

The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.

Latest News

news-by-category

VIEW MORE NEWS

Take Your Next Step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right